首页> Diabetes research and clinical practice> Serum fructosamine and glycemic status in the presence of the sickle cell mutation.

Serum fructosamine and glycemic status in the presence of the sickle cell mutation.

导出 OA

翻译打印收藏纠错

第一作者： Ayo P,Doumatey

第一单位： Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, 12 South Drive, Room 4047, Bethesda, MD 20892, United States. Electronic address: doumateya@mail.nih.gov.

作者： Ayo P,Doumatey ^[1] ; Hermon,Feron ^[2] ; Kenneth,Ekoru ^[2] ; Jie,Zhou ^[2] ; Adebowale,Adeyemo ^[2] ; Charles N,Rotimi ^[3]

作者单位： Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, 12 South Drive, Room 4047, Bethesda, MD 20892, United States. Electronic address: doumateya@mail.nih.gov. ^[1] Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, 12 South Drive, Room 4047, Bethesda, MD 20892, United States. ^[2] Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, 12 South Drive, Room 4047, Bethesda, MD 20892, United States. Electronic address: rotimic@mail.nih.gov. ^[3]

关键词 Africans Clinical thresholds Reference interval Serum fructosamine Sickle cell trait Type 2 diabetes

医学主题词贫血, 镰状细胞性(Anemia, Sickle Cell);糖尿病, 2型(Diabetes Mellitus, Type 2);果糖胺(Fructosamine);人类(Humans);突变(Mutation)

DOI 10.1016/j.diabres.2021.108918

PMID 34126128

发布时间 2022-12-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交